Welcome to the Grabocka Lab.

We are dedicated to addressing therapeutic resistance in RAS-driven and pancreatic cancers, with focus on improving patient outcomes through our research. 

​

Supported by: 

• American Cancer Society

• Gail V. Coleman-Kenneth M. Bruntel Charitable Grant

• NIH/NCI